Molecular Structure, Binding Affinity, and Biological Activity in the Epigenome.

Area of Science:

• Epigenetics and Drug Discovery
• Medicinal Chemistry
• Structural Biology

Background:

• Epigenetic diseases arise from alterations in gene expression without changes to the underlying DNA sequence.
• Proteins involved in epigenetic regulation are key targets for novel therapeutic interventions.
• Understanding structure-activity relationships (SARs) is essential for developing effective epigenetic drugs.

Purpose of the Study:

• To review methodologies and applications for developing valid SARs in epigenetics.
• To emphasize emerging trends and challenges in SAR discovery for epigenetic drug targets.
• To provide a classification of the molecular basis of epigenetic changes.

Main Methods:

• Survey of experimental techniques including cryo-electron microscopy, protein crystallography, and isothermal titration calorimetry.
• Inclusion of frequently used assays and high-throughput screening methods.
• Integration of theoretical approaches alongside experimental data for SAR development.

Main Results:

• Demonstration of how diverse experimental and theoretical methods synergistically contribute to valid SARs.
• Identification of key data types (molecular structure, binding affinity, biological activity) for SAR development.
• Highlighting the importance of proteins as targets in epigenetic drug discovery.

Conclusions:

• Valid SARs are pivotal for elucidating epigenetic disease mechanisms and designing targeted therapies.
• A combination of advanced and conventional methods, alongside computational approaches, is vital for robust SAR discovery.
• Continued research into SARs will accelerate the development of novel epigenetic drugs.